NutriBand (NTRB) Preferred Shares (2025 - 2026)
NutriBand (NTRB) posted Preferred Shares of $3009.0 for Q2 2026, little changed sequentially from $3009.0 in Q1 2026.
NutriBand (NTRB) Preferred Shares (2025 - 2026) Analysis & Trends
NutriBand has reported Preferred Shares for 2 years, with the latest figure at $3009.0 in Q2 2026.
- Quarterly Preferred Shares changed N/A year-over-year to $3009.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3009.0 (changed N/A YoY) and the FY2026 annual result came in at $3009.0, changed N/A from the prior year.
- Preferred Shares steadied at $3009.0 in Q2 2026 per NTRB's latest filing, from $3009.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $3009.0 in Q3 2025 and troughed at $3009.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 3,009.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3,009.00 |
| Jan 31, 2026 | 3,009.00 |
| Oct 31, 2025 | 3,009.00 |
| Jul 31, 2025 | 3,009.00 |